Brian OSullivan
Overview
Explore the profile of Brian OSullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
388
Citations
12745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spreafico A, Winquist E, Ho C, OSullivan B, Bouganim N, Chua N, et al.
Curr Oncol
. 2025 Jan;
32(1).
PMID: 39851964
Although the majority of patients with nasopharyngeal carcinoma (NPC) present with early-stage or locoregional disease that can be treated with definitive radiotherapy, approximately 20% of patients experience disease recurrence, and...
2.
Dietrich N, Watson E, Tadic T, Martino R, Bratman S, Cho J, et al.
Oral Oncol
. 2024 Dec;
161():107132.
PMID: 39729971
Objectives: This study aimed to develop a prediction model for feeding tube dependence in a large homogenous cohort of HPV-associated oropharyngeal squamous cell carcinoma (HPV + OPSCC) patients receiving chemoradiotherapy...
3.
Jackson A, Shaw C, OSullivan B, Govender S, Fischer J
N Z Med J
. 2024 Nov;
137(1606):40-48.
PMID: 39607962
Aim: Colorectal cancer (CRC) incidence is highest in older patients, who also have high rates of concurrent multimorbidity and frailty. Shared decision making is important when deciding treatment. The aim...
4.
Wihlidal J, Esemezie A, Huang S, Watson E, Gilbert R, Waldron J, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1317-1318.
PMID: 39572500
No abstract available.
5.
Rooney C, Huang S, Su J, Bratman S, Cho J, De Almeida J, et al.
Head Neck
. 2024 Oct;
47(3):847-855.
PMID: 39474724
Background: We investigate the association of postoperative radiotherapy (PORT) volumes and salivary function in oral cavity SCC (OSCC). Methods: OSCC patients undergoing PORT 2005-2021 underwent modified Schirmer test (MST) pre-PORT,...
6.
Wihlidal J, Esemezie A, Huang S, Watson E, Gilbert R, Waldron J, et al.
Ann Surg Oncol
. 2024 Oct;
32(2):1270-1279.
PMID: 39467971
Background: Multidisciplinary care is paramount in patient-specific decision making, especially as pertaining to oral cavity squamous cell cancer (OCSCC) treatment. Protracted surgery-postoperative-radiation (S-PORT) has a detrimental impact on OCSCC patients'...
7.
Pan J, Mai H, Ng W, Hu C, Li J, Chen X, et al.
JAMA Oncol
. 2024 Oct;
PMID: 39388190
Importance: Accurate staging is a fundamental step in treating patients with nasopharyngeal carcinoma (NPC) worldwide; this is crucial not only for prognostication, but also for guiding treatment decisions. The American...
8.
von Buchwald C, Jakobsen K, Fenger Carlander A, Tous S, Gronhoj C, Rasmussen J, et al.
Eur J Cancer
. 2024 Sep;
211:114329.
PMID: 39293346
Purpose: The assessment of p16INK4a (p16) in oropharyngeal squamous cell carcinoma (OPSCC) has been incorporated into tumor classification, as p16 has been shown to impact survival probability. However, a recent...
9.
Alsheikh S, Su J, OSullivan B, Ringash J, Waldron J, Bratman S, et al.
Oral Oncol
. 2024 Aug;
158:107007.
PMID: 39173454
Objectives: Clinical extranodal extension (cENE) is a cN modifier in TNM-8 for laryngo-hypopharygeal carcinoma (LHC). We hypothesize that image-detected ENE (iENE) can provide additional prognostic value over cENE in LHC....
10.
Li J, Blanchard P, Wong C, Ahn Y, Bonomo P, Bresson D, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1294-1306.
PMID: 39009321
Locally recurrent nasopharyngeal carcinoma (NPC) presents substantial challenges in clinical management. Although postoperative re-irradiation (re-RT) has been acknowledged as a potential treatment option, standardized guidelines and consensus regarding the use...